About

Mr. Shawah is a co-founder of Acurx Pharmaceuticals and has served as its Chief Financial Officer since June 2021, having previously served as the company's Chief Accounting Officer and Vice President of Finance from February 2018 to June 2021. Earlier he was Chief Accounting Officer of Dipexium Pharmaceuticals, Inc. (Nasdaq: DPRX) from 2014 until its April 2017 sale to PLx Pharma. He has also served as Vice President of Baldwin Pearson & Co., Inc., a commercial real estate firm, and as a director of Ameri100, a software integration company. Mr. Shawah, a certified public accountant, graduated from Bucknell University with a B.S. in Business Administration with a concentration in Accounting.

Roles

Acurx Pharmaceuticals, Inc.
Co-Founder & Chief Financial Officer · Current role
June 2021–present
Acurx Pharmaceuticals, Inc.
Co-Founder & Chief Financial Officer
2021 - present
Acurx Pharmaceuticals, Inc.
Chief Accounting Officer & VP of Finance
2018 - 2021
Dipexium Pharmaceuticals, Inc.
Chief Accounting Officer
2014 - 2017
Baldwin Pearson & Co., Inc.
Vice President
—
Ameri100
Director
2018

Fixed Compensation

FY 2024
Salary
$395,840
ComponentAnnual base salary earned in 2024
Total compensation
$907,463

Performance Compensation

Data from FY 2024

Cash incentive

Bonus
$137,813
Target Opportunity
—
PlanAnnual performance-based cash bonus

Stock awards

Option awards
$373,810
FormStock options, ASC 718 grant-date fair value

Also at Acurx Pharmaceuticals, Inc.

Related

See how Top Bucket AI works for your firm

Request Demo
Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

✓

You're subscribed.

Thanks for signing up.